Article

 

Examining the Use of Ceftaroline in the Treatment of Streptococcus pneumoniae Meningitis with Reference to Human Cathelicidin LL-37 Public Deposited

Downloadable Content

Download PDF
https://ir.library.oregonstate.edu/concern/articles/8g84mn867

Descriptions

Attribute NameValues
Creator
Abstract
  • Five cases of bacterial meningitis treated with ceftaroline (4 Streptococcus pneumoniae and 1 Staphylococcus aureus) are summarized here. The pharmacodynamics of human cathelicidin LL-37 and ceftaroline were evaluated against S. pneumoniae. Patients who received ceftaroline 600 mg every 8 h (q8h) (1 S. aureus and 3 S. pneumoniae) were successfully treated; treatment failed in 1 patient with S. pneumoniae who received 600 mg q12h. Ceftaroline increased the negative surface charge and sensitized S. pneumoniae to killing by LL-37, a peptide implicated in blood-brain barrier defense.
Resource Type
DOI
Date Available
Date Issued
Citation
  • Sakoulas, G., Nonejuie, P., Kullar, R., Pogliano, J., Rybak, M. J., & Nizet, V. (2015). Examining the Use of Ceftaroline in the Treatment of Streptococcus pneumoniae Meningitis with Reference to Human Cathelicidin LL-37. Antimicrobial agents and chemotherapy, 59(4), 2428-2431. doi:10.1128/AAC.04965-14
Journal Title
Journal Volume
  • 59
Journal Issue/Number
  • 4
Academic Affiliation
Rights Statement
Funding Statement (additional comments about funding)
  • Funding for this research was provided by U54 HD071600-0109/26/2011-06/30/2016 NICHD on Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy (to G.S. and V.N.).G.S. has received speaking honoraria from Cubist, Forest, and Novartis Pharmaceuticals, consulting fees from Cubist and Forest Pharmaceuticals, and research grant support from Forest Pharmaceuticals. M.J.R. has received speaking honoraria from Cubist, Forest, Novartis, and Sunovion, consulting fees from Durata, Cubist, Forest, Cepheid, and Theravance, and research grant support from Cubist, Forest, and Cerexa Pharmaceuticals.
Publisher
Peer Reviewed
Language
Replaces
Additional Information
  • description.provenance : Submitted by Patricia Black (patricia.black@oregonstate.edu) on 2015-08-03T20:34:46Z No. of bitstreams: 1 KullarRavinaPharmacyExaminingUseCeftaroline.pdf: 627220 bytes, checksum: 6fe3cdc1ce100c6bfe976861562495f1 (MD5)
  • description.provenance : Made available in DSpace on 2015-08-03T20:35:01Z (GMT). No. of bitstreams: 1 KullarRavinaPharmacyExaminingUseCeftaroline.pdf: 627220 bytes, checksum: 6fe3cdc1ce100c6bfe976861562495f1 (MD5) Previous issue date: 2015-04
  • description.provenance : Approved for entry into archive by Patricia Black(patricia.black@oregonstate.edu) on 2015-08-03T20:35:01Z (GMT) No. of bitstreams: 1 KullarRavinaPharmacyExaminingUseCeftaroline.pdf: 627220 bytes, checksum: 6fe3cdc1ce100c6bfe976861562495f1 (MD5)

Relationships

Parents:

This work has no parents.

Items